FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Rep. DeLauro Seeks Ban on DTC Ads, Again

[ Price : $8.95]

Congresswoman Rosa DeLauro (D-CT) reintroduces a bill (HR 4385) that would amend the Food, Drug, and Cosmetic Act to restrict dire...

Docket Number Correction for ANDA Controlled Correspondence

[ Price : $8.95]

Federal Register notice: FDA corrects an 11/3 Federal Register notice entitled Controlled Correspondence Related to Generic Drug D...

Expedited Programs for Regenerative Medicines Draft Guidance

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance on Expedited Programs for Regenerative Medicine Therapies for Seriou...

FDA Panel Votes Down Bayers Ciprofloxacin for Bronchiectasis

[ Price : $8.95]

FDAs Antimicrobial Drugs Advisory Committee votes 9 to 6 against recommending approval for Bayer HealthCare Pharmaceuticals ciprof...

Pfizers Greenstone Recalls Super/Sub Potent Drugs

[ Price : $8.95]

Pfizer subsidiary Greenstone recalls multiple lots of diphenoxylate hydrochloride and atropine sulfate tablets because the product...

Gottlieb Steps in to Ease Hospital Product Shortages

[ Price : $8.95]

FDA commissioner Scott Gottlieb says the agency is taking steps to improve certain drug shortages at hospitals caused by hurricane...

Direct Device Marking Guidance

[ Price : $8.95]

FDA issues a guidance answering questions about the direct marking of medical devices under the unique device identification regul...

Leave Battlefield Medical Decisions to FDA: Senate Vote

[ Price : $8.95]

The Senate approves a House bill retaining FDA authority over battlefield drug and medical device decisions.

Genentechs Gazyva OKd for Advanced Follicular Lymphoma

[ Price : $8.95]

FDA approves Genentechs Gazyva (obinutuzumab) in combination with chemotherapy, followed by Gazyva alone in those who responded, f...

Bone Drugs Panel to Review Lipocine Testosterone NDA

[ Price : $8.95]

Federal Register notice: FDA announces a 1/10/2018 Bone, Reproductive and Urologic Drugs Advisory Committee meeting that will disc...